ACRV - Acrivon Therapeutics, Common Stock - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ACRV is currently covered by 6 analysts with an average price target of $15.35. This is a potential upside of $14.13 (1158.2%) from yesterday's end of day stock price of $1.22.

Acrivon Therapeutics, Common Stock's activity chart (see below) currently has 3 price targets and 26 ratings on display. The stock rating distribution of ACRV is 95.65% BUY and 4.35% HOLD.

Stock Analyst Price Targets - Review

Highest price target for ACRV is $27, Lowest price target is $16, average price target is $22.33.

Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 14-Nov-2024. First documented stock forecast 09-Dec-2022.

Best performing analysts who are covering ACRV - Acrivon Therapeutics, Common Stock:

Emily Bodnar Etzer Darout Silvan Tuerkcan Aydin Huseynov Joseph Catanzaro Soumit Roy

Currently out of the existing stock ratings of ACRV, 22 are a BUY (95.65%), 1 are a HOLD (4.35%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$22

$20.8 (1733.33%)

$22

7 months 2 days ago
(14-Nov-2024)

0/8 (0%)

$14.08 (177.78%)

Buy

$27

$25.8 (2150.00%)

$28

7 months 2 days ago
(14-Nov-2024)

0/6 (0%)

$19.08 (240.91%)

Buy

$17

$15.8 (1316.67%)

$17

9 months ago
(16-Sep-2024)

0/4 (0%)

$8.77 (106.56%)

Buy

$16

$14.8 (1233.33%)

9 months ago
(16-Sep-2024)

0/2 (0%)

$7.77 (94.41%)

Buy

$30

$28.8 (2400.00%)

$25

1 years 1 months 22 days ago
(25-Apr-2024)

0/2 (0%)

$21.53 (254.19%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACRV (Acrivon Therapeutics, Common Stock) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ACRV (Acrivon Therapeutics, Common Stock) with a proven track record?

EMILY BODNAR

Which analyst has the current lower performing score on ACRV (Acrivon Therapeutics, Common Stock) with a proven track record?

SOUMIT ROY

Which analyst has the most public recommendations on ACRV (Acrivon Therapeutics, Common Stock)?

Emily Bodnar has 15 price targets and 16 ratings on ACRV

Which analyst is the currently most bullish on ACRV (Acrivon Therapeutics, Common Stock)?

Joseph Catanzaro with highest potential upside - $28.8

Which analyst is the currently most reserved on ACRV (Acrivon Therapeutics, Common Stock)?

Aydin Huseynov with lowest potential downside - $14.8

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?